Literature DB >> 26628429

Presence of an H+/Quinidine Antiport System in Madin-Darby Canine Kidney Cells.

Miki Fukao1, Eri Kondo1, Hiroki Nishino1, Ryutaro Hattori1, Asuka Horie1, Yukiya Hashimoto2.   

Abstract

BACKGROUND AND OBJECTIVES: We have recently found an H+/quinidine antiport system in human kidney HEK 293 cells. The aim of the present study was to evaluate whether the H+/quinidine antiport system is expressed in Madin-Darby canine kidney (MDCK) cells.
METHODS: We investigated the uptake and efflux of quinidine in MDCK cells.
RESULTS: The uptake of 100 µM quinidine into MDCK cells was decreased by acidification of extracellular pH or alkalization of intracellular pH. In addition, the uptake of quinidine was highly temperature sensitive, but was extracellular Na+ and membrane potential independent. Furthermore, tetraethylammonium, a typical substrate of renal organic cation transporters, did not inhibit the uptake of quinidine in MDCK cells. On the other hand, lipophilic cationic drugs, such as clonidine, bisoprolol, diphenhydramine, pyrilamine, and imipramine, significantly decreased the uptake of quinidine in MDCK cells. The uptake of quinidine was saturable, and the Michaelis-Menten constant was estimated to be approximately 0.5 mM. In addition, the efflux of quinidine from MDCK cells was increased by the acidification of extracellular pH, suggesting that the transport system mediates not only the uptake, but also secretion of quinidine.
CONCLUSIONS: The present findings suggested that the renal new antiport system is involved in the bidirectional membrane transport of quinidine in MDCK cells.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26628429     DOI: 10.1007/s13318-015-0314-1

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  12 in total

1.  Elimination of flecainide as a function of urinary flow rate and pH.

Authors:  R Hertrampf; U Gundert-Remy; J Beckmann; U Hoppe; W Elsässer; H Stein
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Influence of urine pH and urinary flow on the renal excretion of memantine.

Authors:  S Freudenthaler; I Meineke; K H Schreeb; E Boakye; U Gundert-Remy; C H Gleiter
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

Review 3.  Organic cation transporter OCTs (SLC22) and MATEs (SLC47) in the human kidney.

Authors:  Hideyuki Motohashi; Ken-ichi Inui
Journal:  AAPS J       Date:  2013-02-22       Impact factor: 4.009

4.  Membrane transport mechanisms of choline in human intestinal epithelial LS180 cells.

Authors:  Asuka Horie; Kazuya Ishida; Yuri Watanabe; Kaito Shibata; Yukiya Hashimoto
Journal:  Biopharm Drug Dispos       Date:  2014-10-29       Impact factor: 1.627

5.  Membrane transport mechanisms of quinidine and procainamide in renal LLC-PK1 and intestinal LS180 cells.

Authors:  Miki Masago; Mari Takaai; Jumpei Sakata; Asuka Horie; Toshikazu Ito; Kazuya Ishida; Masato Taguchi; Yukiya Hashimoto
Journal:  Biol Pharm Bull       Date:  2010       Impact factor: 2.233

6.  Transport characteristics of diphenhydramine in human intestinal epithelial Caco-2 cells: contribution of pH-dependent transport system.

Authors:  H Mizuuchi; T Katsura; H Saito; Y Hashimoto; K I Inui
Journal:  J Pharmacol Exp Ther       Date:  1999-07       Impact factor: 4.030

7.  Variability of bioavailability and intestinal absorption characteristics of bisoprolol.

Authors:  Kazuya Ishida; Asuka Horie; Maki Nishimura; Masato Taguchi; Nozomu Fujii; Takashi Nozawa; Hiroshi Inoue; Yukiya Hashimoto
Journal:  Drug Metab Pharmacokinet       Date:  2013-05-28       Impact factor: 3.614

8.  Directional transcellular transport of bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 cells, but not in renal epithelial LLC-PK1 Cells.

Authors:  Katsutoshi Tahara; Yuka Kagawa; Mari Takaai; Masato Taguchi; Yukiya Hashimoto
Journal:  Drug Metab Pharmacokinet       Date:  2008       Impact factor: 3.614

9.  Pharmacokinetic variability of flecainide in younger Japanese patients and mechanisms for renal excretion and intestinal absorption.

Authors:  Asuka Horie; Kazuya Ishida; Kaito Shibata; Masato Taguchi; Ayaka Ozawa; Keiichi Hirono; Fukiko Ichida; Yukiya Hashimoto
Journal:  Biopharm Drug Dispos       Date:  2013-11-20       Impact factor: 1.627

Review 10.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.